sg 209 has been researched along with natriuretic peptide, c-type in 1 studies
| Studies (sg 209) | Trials (sg 209) | Recent Studies (post-2010) (sg 209) | Studies (natriuretic peptide, c-type) | Trials (natriuretic peptide, c-type) | Recent Studies (post-2010) (natriuretic peptide, c-type) |
|---|---|---|---|---|---|
| 15 | 0 | 3 | 1,413 | 31 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotsikoris, V; Papapetropoulos, A; Pyriochou, A; Topouzis, S; Umaru, B | 1 |
1 other study(ies) available for sg 209 and natriuretic peptide, c-type
| Article | Year |
|---|---|
ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo.
Topics: Animals; Cell Line; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Collagen; Drug Combinations; Endothelial Cells; Endothelium, Vascular; Humans; KATP Channels; Laminin; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Natriuretic Peptide, C-Type; Neovascularization, Physiologic; Niacinamide; Proteoglycans; Proto-Oncogene Proteins c-akt; RNA, Small Interfering | 2015 |